A picture tells 1,000 words. Have been working on improving the format of my analysis for a while.
Figured it's time to share. Will add snippets to this as I find the time.
DYOR. This comparative analysis is not intended as financial advice. You are encouraged to do your own research and make your own investment decisions. Disclosures - held, sentiment bullish/long. This is my own analysis and I have not received compensation for it.Buyout potential $32 to $138.
Partnership potential $7 to $13
( could also be the path to a buyout in perhaps a 3 year timeframe, with partnership milestones funding ongoing development )
The PDF has links to source references for peer analysis data.
Make sure you watch the following videos.
This one is the content covered at the 2020 AGM.
This one from late November 2020.
RAC Upside - promising forgotten cancer drug that works
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.22 |
Change
-0.010(0.81%) |
Mkt cap ! $202.7M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.26 | $1.14 | $381.6K | 320.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7000 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.22 | 2171 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.17 |
Change
-0.010 ( 5.54 %) |
||||
| Open | High | Low | Volume | ||
| $1.23 | $1.23 | $1.14 | 48407 | ||
| Last updated 15.52pm 03/05/2024 ? | |||||
| RAC (ASX) Chart |